IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Finch Therapeutics Group Inc

CUSIP: 31773D101 | 88 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Avenir Management Company, LLC55,445
1.3% of portfolio›$472.9K
StyleTurnoverLocationFiled
Avenir Management Company, LLC
55,445$472.9K1.3%N/AN/ACoconut Grove, FL2023-08-14